Circular RNA (circRNA) resists cellular exonuclease degradation due to its closed-loop structure, demonstrating vastly longer in vivo half-lives and sustained protein expression compared to linear mRNA. Its reduced innate immunogenicity and durable expression profile position circRNA as a superior therapeutic platform for chronic protein replacement therapies. nature.com